One undescribed amide, pipermullesine A, two undescribed isoquinoline alkaloids, pipermullesines B and C, and six undescribed dipeptides, pipermullamides A-F, along with 28 known compounds, were isolated from the aerial parts of Piper mullesua. The structures of the undescribed compounds were elucidated based on the analysis of 1D and 2D NMR and MS data. Furthermore, the structures of pipermullesines A-C were confirmed by single crystal X-ray diffraction analysis. All isolates were evaluated for inhibitory activity against platelet aggregation induced by thrombin (IIa) or platelet-activating factor (PAF). (-)-Mangochinine, pellitorine, and (2E,4E)-N-isobutyl-2,4-dodecadienamide showed weak inhibitory activity against rabbit platelet aggregation induced by PAF, with IC 50 values of 470.3 µg/mL, 614.9 µg/mL, and 579.7 µg/mL, respectively.
Structure Elucidation
Nine undescribed compounds (1-9, Fig. 1 ) and 28 known ones were isolated from the methanolic extracts of P. mullesua by silica gel, D101 resin and Sephadex LH-20 column chromatography and semipreparative HPLC.
Pipermullesine A (1) had the molecular formula C 15 H 15 NO 4 based on 13 C NMR (Table 1) (Fig. 2) , (E)-3,4-dimethoxycinnamoyl and 1,4-oxazine groups were confirmed. Although the correlations from H-1″ and H-4″ to C-1 were not observed in the HMBC spectrum, the structure of 1 was finally determined as (E)-3-(3,4-dimethoxyphenyl)-1-(4H-1,4-oxazin-4-yl) prop-2-en-1-one by a single-crystal X-ray diffraction analysis (Fig. 3) .
The molecular formula of pipermullesine B (2), C 16 H 22 N 2 O 3 , was determined by 13 C NMR data (Table 2 ) and an HREIMS ion at m/z 290.1620 [M] ? (calcd for C 16 (Table 2 ) exhibited 15 signals. However, according to its HREIMS data, compound 2 should have 16 carbon atoms. The disappeared signal for C-9 (δ C 33.0) was detected by the HMBC correlation ( Fig. 2 ) from H 2 -11 to C-9.
1 H-1 H COSY correlations ( Fig. 2 ) exhibited two partial structures comprising C-2 to C-3 and C-10 to C-12. On the basis of the HMBC correlations from H 2 -3 to C-1 and C-4a, H 2 -4 to C-5 and C-8a, H-5 to C-7 and C-8a, H-8 to C-1, C-4a, and C-6, and 7-OMe to C-7, a 6-hydroxy-7-methoxy-3,4-dihydroisoquinoline fragment with a substituent group at C-1 was confirmed. The group at C-1 was deduced as 4-acetamidobutyl by the HMBC correlations from H 2 -10 to C-1, H 2 -11 to C-9 and C-1′, and H 3 -2′ to C-1′. Thus, the structure of 2 was determined as 1-(4-acetamidobutyl)-6-hydroxy-7-methoxy-3,4-dihydroisoquinoline and given the common name pipermullesine B.
The crystals for pipermullesine B trifluoroacetate (2a) were obtained from methanol. The NMR data of 2a (Table 2 ) and the result of its single-crystal X-ray diffraction analysis (Fig. 3) further supported the structure elucidation of 2.
Pipermullesine C (3) yielded a molecular formula of C 22 H 30 N 4 O 4 with 10 degrees of unsaturation, as deduced by 13 C NMR (Table 3 ) and the HREIMS data. A comparison of the NMR data (Tables 2, 3) On the basis of 2D NMR correlations (Fig. 2) , a 1-(4-acetamidobutyl)-6-hydroxy-3,4-dihydroisoquinoline moiety was determined. One more ring is needed to meet the unsaturation, and the ring was deduced as an oxazole ring attached to C-7 and C-8 by comparison of the NMR data with those of benzoxazoles in the literature [15, 16] . The additional 4-acetamidobutyl group was located at C-1′′ of the oxazole ring by the HMBC correlation from H-3′′ to C-1′′. Thus, the structure of 3 (pipermullesine C) was determined.
Fortunately, the crystals for pipermullesine C trifluoroacetate (3a) were also obtained from methanol. The NMR data of 3a (Table 3 ) and the result of its singlecrystal X-ray diffraction analysis (Fig. 3) confirmed the chemical structure of 3.
The molecular formula of pipermullamide A (4), C 18 H 28 N 2 O 3 , was determined by 13 C NMR data (Table 4 ) and an HREIMS ion at 320.2102 [M] ? (calcd for . By comparing the NMR data of 4 with those of phenylalanine and leucine trimethylbetaine [17, 18] , compound 4 might comprise the two fragments, which was confirmed through its 1 H-1 H COSY and HMBC correlations (Fig. 2) . The amino of phenylalanine was acylated by the carboxyl group of leucine trimethylbetaine according to the HMBC correlation from H-8′ to C-1.
Natural amino acids generally have an L configuration. Compound 10 from the plant is also a derivative of Lphenylalanine. Accordingly, compound 4 (pipermullamide A) was elucidated as L-(N,N,N-trimethyl)leucyl-Lphenylalanine.
The molecular formulae of pipermullamides B to F (5-9) were determined as C 18 
The known compounds (?)-phenylalanine betaine (10) [19] , (-)-mangochinine (11) [20] , xylopinidine (12) [21] , (-)-oblongine (13) [22] , pellitorine (14) [23] , (2E,4E)-Nisobutyl-2,4-dodecadienamide (15) [24] , retrofractamide A (16) [23] , guineensine (17) [23] , brachystamide B (18) [25] , retrofractamide C (19) [26] , sarmentine (20) [27], 3-(3,4-dimethoxyphenyl)propanoylpyrrole (21) [28] , Ntrans-feruloyltyramine (22) [29] , (-)-machilusin (23) [30] , galgravin (24) [31], (-)-nectandrin A (25) [32] , methyl 3-(3,4-dimethoxyphenyl)propanoate (26) [33] , piperic acid (27) [34] , methyl piperate (28) [34] , methyl (2E,4E)-7-(1,3-benzodioxol-5-yl)hepta-2,4-dienoate (29) [35] , (-)-blumenol B (30) [36] , (-)-T-muurolol (31) [37] , trans-phytol (32) [38] , α-tocopherolquinone (33) [39] , γ-tocopherol (34) [40] , stigmast-4-ene-3,6-dione (35) [41] , (22E)-stigmasta-4,22-diene-3,6-dione (36) [42] , and (22E)-stigmasta-4,6,8 
In Vitro Platelet Aggregation Assay
All isolates (1-37) were evaluated for inhibitory activity against platelet aggregation induced by thrombin (IIa) or PAF. As shown in Tables 6 and 7 , compounds 2, 3, 5, 14, 27, 33, and 34 possessed weak inhibitory effects on the aggregation of rabbit platelets induced by thrombin (IIa) (1 U/mL) with inhibition rates from 11.5 to 22.2% at a concentration of 300 µg/mL. Compounds 11, 14, 15, 20, and 25 showed weak inhibitory activity against the rabbit platelet aggregation induced by PAF (0.4 µg/mL) with inhibition rates from 16.8% to 36.4% at a concentration of 300 µg/mL, while (-)-mangochinine (11), pellitorine (14) , and (2E,4E)-N-isobutyl-2,4-dodecadienamide (15) have IC 50 values of 470.3 µg/mL, 614.9 µg/mL, and 579.7 µg/mL, respectively. The antiplatelet activity of (-)-mangochinine and (2E,4E)-Nisobutyl-2,4-dodecadienamide was reported for the first time. The other tested compounds were inactive.
More than fifty antiplatelet compounds, mainly including alkaloids and amides, lignans and neolignans, and phenylpropanoids, have been isolated from the Piper genus [44] . Pellitorine is a very interesting compound with various biological activities, such as an inhibitory effect on platelet aggregation induced by arachidonic acid (IC 50 = 53.0 μg/mL) [45] , antituberculosis activity (MIC=25 µg/ mL) [46] , antifungal activity against Cryptococcus neoformans (IC 50 =7.7 μg/mL) [47] , and α-glucosidase-I enzyme inhibitory activity (IC 50 =34.39 μg/mL) [48] . Although its in vitro activity against platelet aggregation is weak, the amide shows strong in vivo anticoagulant activities at a dose of 4.5 μg/mouse or 9.0 μg/mouse [49] . It is worthwhile to conduct further in vivo antithrombotic studies of pellitorine along with (-)-mangochinine and (2E,4E)-N-isobutyl-2,4-dodecadienamide.
Experimental Section

General Experimental Procedures
The instruments and materials for isolation and identification of compounds from the herb were presented in Supplementary Material. 
Plant Material
The 
Extraction and Isolation
The air-dried, powdered P. mullesua plant (1.8 kg) was exhaustively extracted with MeOH (4910 L) at room temperature. The MeOH extracts (92.5 g) were suspended in H 2 O and further partitioned with petroleum ether and CHCl 3 . The petroleum ether-soluble part (31.2 g) and CHCl 3 -soluble part (4.8 g) were combined (36.0 g, part B) according to the testing results of thin-layer chromatography. The water phase was partitioned by D101 resin column chromatography to obtain the water-eluted part (discarded) and 95% EtOH-eluted part (7.2 g, part A).
Part A was subjected to column chromatography (silica gel; CHCl 3 /MeOH, 10:1→0:1, v/v) to yield three fractions (A1-A3). Fraction A1 was separated on an RP-18 silica gel column eluted with MeOH/H 2 O (10%→100%). The 40% MeOH-eluted portion was purified by Sephadex LH-20 column chromatography (MeOH) and semi-preparative HPLC (Aligent Zorbax SB-C 18 column, 109250 mm, 2 mL/min) to obtain 3 (6.5 mg, MeOH/H 2 O, 80:20, t R = 12.150 min) and 11 (6.9 mg, MeCN/H 2 O, 15:85, t R = 5.190 min).
Fraction A2 was separated on an RP-18 silica gel column eluted with MeOH/H 2 O (10%→100%) to yield two main subfractions. The 5% MeOH-eluted portion was purified by Sephadex LH-20 column chromatography (MeOH) to yield two main subfractions (A2-1-1 and A2-1-2). Subfraction A2-1-1 was performed on preparative TLC (CHCl 3 /MeOH, 3:1) to obtain 2 (4.3 mg). Subfraction A2-1-2 was recrystallized from MeOH to obtain 10 (23.5 mg). Part B was subjected to column chromatography (silica gel; petroleum ether/acetone, 20:1→0:1, v/v) to yield five fractions (B1-B5). Fraction B1 was separated on an RP-18 silica gel column eluted with MeOH/H 2 O (10%→100%) to yield four main subfractions. The 70% MeOH-eluted portion was purified by Sephadex LH-20 column chromatography (MeOH) and silica gel column chromatography (petroleum ether/acetone, 40:1, v/v) to obtain 28 (3.3 mg) and 29 (4.9 mg). The 85% MeOH-eluted portion was purified by Sephadex LH-20 column chromatography (MeOH) and preparative TLC (petroleum ether/EtOAc, 20:1, v/v) to obtain 32 (13.5 mg). The 90% MeOH-eluted portion was purified by Sephadex LH-20 column chromatography (MeOH) to obtain 31 (2.3 mg) recrystallized from MeOH. The 95% MeOH-eluted portion was purified by Sephadex LH-20 column chromatography (MeOH) and semipreparative HPLC (Aligent Zorbax SB-C 18 column, 109250 mm, MeOH/H 2 O, 100:0, 2 mL/min) to obtain 34 (6.0 mg, t R =19.574 min) and 37 (1.5 mg, t R =26.868 min).
Fraction B2 was separated on an RP-18 silica gel column eluted with MeOH/H 2 O (10%→100%) to yield two main subfractions. The 80% MeOH-eluted portion was purified by Sephadex LH-20 column chromatography (MeOH) and semipreparative HPLC (Aligent Zorbax SB-C 18 C NMR data, see Table 2 .
Crystal data for pipermullesine B trifluoroacetate (2a): C NMR data, see Table 3 .
Crystal data for pipermullesine C trifluoroacetate (3a): C 22 
In vitro Platelet Aggregation Assay
The inhibitory effects of compounds against rabbit platelet aggregation induced by PAF or Thrombin (IIa) were evaluated according to the published methods [50] [51] [52] [53] . The details were presented in Supplementary Material.
Conclusion
Thirty-seven compounds were isolated from the folk Chinese medicine Piper mullesua with the "Huayu" function associated with the antiplatelet therapies. The antiplatelet compounds, especially (-)-mangochinine, pellitorine, and (2E,4E)-N-isobutyl-2,4-dodecadienamide, might be scientific evidence to support the traditional use of the plant as folk medicine. In order to make better use of the folk medicine to serve for human health, further research needs to be conducted on bioguided isolation of compounds from the plant, based on both in vitro and in vivo bioassay testing.
